Adrenal Liquescence
NDC 83027-0014, Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin, liquid, from Nutritional Specialties, Inc..
- Product NDC
- 83027-0014
- Status
- Listed
- Labeler
- Nutritional Specialties, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCYRRHIZA GLABRA2 [hp_X]/mL
- ROSA CANINA FRUIT3 [hp_X]/mL
- AMERICAN GINSENG3 [hp_X]/mL
- BOS TAURUS ADRENAL GLAND6 [hp_X]/mL
- EPINEPHRINE12 [hp_X]/mL
- EPHEDRA DISTACHYA FLOWERING TWIG12 [hp_X]/mL
- SODIUM CHLORIDE12 [hp_X]/mL
- ZINC12 [hp_X]/mL
- CORTICOTROPIN15 [hp_C]/mL
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83027-0014-1 | 83027001401 | 120 mL in 1 BOTTLE, GLASS (83027-0014-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83027-0014 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0014 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83027-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.